Novel Drugs in Follicular Lymphoma - Wikidata - thesis-toulmin - TriplyDB

Novel Drugs in Follicular Lymphoma

Novel Drugs in Follicular Lymphoma

http://www.wikidata.org/entity/Q28076335

about

Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.

P2860

Q47618290-E69BA573-A0F7-4B72-97B8-5F467A28A229

P2860

Novel Drugs in Follicular Lymphoma

http://www.wikidata.org/entity/Q28076335

description

2016 nî lūn-bûn

@nan

2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Novel Drugs in Follicular Lymphoma

@ast

Novel Drugs in Follicular Lymphoma

@en

Novel Drugs in Follicular Lymphoma

@nl

type

label

Novel Drugs in Follicular Lymphoma

@ast

Novel Drugs in Follicular Lymphoma

@en

Novel Drugs in Follicular Lymphoma

@nl

prefLabel

Novel Drugs in Follicular Lymphoma

@ast

Novel Drugs in Follicular Lymphoma

@en

Novel Drugs in Follicular Lymphoma

@nl

P1433

Q28076335-9DB37379-7210-44BD-9609-30FA30CE828D

P1476

Q28076335-02988EAB-FC00-43A0-B7EE-B4F6B826C105

P2093

Q28076335-065E6818-FD60-4385-91CA-3B9FD744E604

Q28076335-95FBACC9-851D-40AC-8E6D-367814F11130

P2860

Q28076335-07732A2D-1FD9-412A-839B-B3811ADB84D9

Q28076335-0B59A0F5-C558-4803-AEE1-1591EE649ECE

Q28076335-12159857-2C4D-4B45-B140-497C7B9955C9

Q28076335-17CB3768-B956-415B-8C23-5F02968B8039

Q28076335-1AA09CF6-6284-46F3-9B0A-4D7AAB72F5F8

Q28076335-1B8EFC4F-A511-4CE3-9899-CBC5C30374F8

Q28076335-22583BEF-FE5E-457A-8D2B-98E62FDA0D59

Q28076335-2B5625D8-1775-48BE-AEAA-17D9E21273CD

Q28076335-303F6AA9-04AF-4D4E-994E-4CA39CF97D39

Q28076335-4B12C2B9-3111-42EE-84AE-62F9844ADFF2

P304

Q28076335-C7BE1970-B5A9-4E8A-A524-77E738847055

P31

Q28076335-9BEAAC3B-1111-4A7E-A823-56355A60E593

P356

Q28076335-F923FEF1-AA65-46F2-ABC7-D2BBB56DDC51

P407

Q28076335-28EF474E-3E09-4DB5-A0DD-95D74CF9D7ED

P433

Q28076335-2C85DDC7-B142-49DE-A0B0-EC4A8FCB28FB

P478

Q28076335-5617D7B0-5CBC-48EF-9EF2-DA06AAE15753

P577

Q28076335-9C71E5B4-D0ED-4708-8FB5-CF9148C1A21E

P698

Q28076335-CCFFCC49-DDA2-48F3-8AB5-B8588E672531

P932

Q28076335-745AF3C1-3F53-4B78-B77E-A3B7ACAE4291

P356

P1433

Mediterranean journal of hematology and infectious diseases

P1476

Novel Drugs in Follicular Lymphoma

@en

P2093

Antonella Anastasia

http://www.w3.org/2001/XMLSchema#string

Giuseppe Rossi

http://www.w3.org/2001/XMLSchema#string

P2860

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

CD19 chimeric antigen receptor (CD19 CAR)-redirected adoptive T-cell immunotherapy for the treatment of relapsed or refractory B-cell Non-Hodgkin's Lymphomas

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.

Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma.

Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma.

Phase II study of vorinostat for treatment of relapsed or refractory indolent non-Hodgkin's lymphoma and mantle cell lymphoma

Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study.

Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma.

A phase 1/1b study of rituximab, bendamustine, and ibrutinib in patients with untreated and relapsed/refractory non-Hodgkin lymphoma.

P304

e2016061

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4084/MJHID.2016.061

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27872741

http://www.w3.org/2001/XMLSchema#string

P932

5111511

http://www.w3.org/2001/XMLSchema#string